
Protego
Protego Bio is a clinical-stage biotech developing first-in-class small molecule pharmacological chaperones for AL amyloidosis and other protein misfolding diseases.
$130M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMay 14, 2024 (2 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $130M | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
PR
Pablo Rojas Co-founder, CEOLinkedIn · source: foundertrace.comRC
Rafael Casabianca Co-Founder & CTO (YC S21)LinkedIn · source: foundertrace.com
Companies like Protego
RRougeTx$58M Series A · Oct 2026
RR1 Therapeutics$80.5M Series A · Sep 2026
VVandria$30.7M Series A · Aug 2024MModel Medicines$4.1M · Nov 2021
NNoema PharmaSeries B+ · Nov 2025
SStorm Therapeutics$56M Series B+ · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/protego-2 (get a free API key).